Respiratory/Pulmonary Market Research Reports & Industry Analysis
Respiratory/Pulmonary Industry Research & Market Reports
-
Anesthesia and Respiratory Devices Market (Product Type: Anesthesia Devices [Anesthesia Machines and Anesthesia Disposables] and Respiratory Devices [Respiratory Equipment, Respiratory Disposables, and Respiratory Measurement Devices]; and End-user: Hospitals, Specialty Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 Anesthesia and Respiratory Devices Market – Scope of Report TMR’s report on the global anesthesia and respiratory devices market studies the past as well as the current ... Read More
-
Bronchoscopy Market Size By Product Type (Rigid Bronchoscopes, Flexible Bronchoscopes), By Product Usage (Single Use/ Disposable, Reusable), By Age Group (Adult, Pediatric), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Forecast, 2022 - 2028 The global bronchoscopy market is expected to grow exponentially by 2028 on account of rising prevalence of lung cancer due to surging rates of indoor and outdoor air pollution. Bronchoscopy is ... Read More
-
Middle East and Africa Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The Middle East and Africa carbapenem-based antibiotics market is expected to reach US$ 297.20 million by 2028 from US$ 237.42 ... Read More
-
Europe Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The Europe carbapenem-based antibiotics market is expected to reach US$ 1,469.86 million by 2028 from US$ 1,128.37 million in 2021; it is estimated ... Read More
-
Asia Pacific Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The Asia Pacific carbapenem-based antibiotics market is expected to reach US$ 1,506.07 million by 2028 from US$ 1,072.76 million in 2021; it ... Read More
-
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... Lung Cancer therapeutics. Synopsis In 2022, there will be more than 210,000 diagnosed prevalent cases of SCLC across 16 pharmaceutical markets. There are three leading marketed drugs for the treatment of SCLC, AstraZeneca is a ... Read More
-
Asia Pacific Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Others), and End User (Pediatric, ICU, Home Care, and Others) The Asia Pacific non-invasive ventilation masks market is expected to reach US$ 581.8 million by 2028 from US$ 384.8 million in 2021. The market is ... Read More
-
Europe Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... and End User (Pediatric, ICU, Home Care, and Others) The Europe non-invasive ventilation masks market is expected to reach US$ 735.24 million by 2028 from US$ 515.45 million in 2021. The market is estimated to ... Read More
-
North America Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Others), and End User (Pediatric, ICU, Home Care, and Others) The North America non-invasive ventilation masks market is expected to reach US$ 985.8 million by 2028 from US$ 671.1 million in 2021. The market is ... Read More
-
South and Central America Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others) The South & Central America non-invasive ventilation masks market is expected to reach US$ 166.2 million by 2028 from US$ 119.8 million in ... Read More
-
North America Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The North America carbapenem-based antibiotics market is expected to reach US$ 1,713.21 million by 2028 from US$ 1,244.59 million in 2021; it ... Read More
-
Middle East and Africa Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others) The Middle East & Africa non-invasive ventilation masks market is expected to reach US$ 114.0 million by 2028 from US$ 84.2 million in ... Read More
-
Bacteriophage Market
... assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the bacteriophage market, growth prospects of the market are obtained with maximum precision. The ... Read More
-
Leading Cystic Fibrosis Therapeutics Distribution Channel Markets Databank
... from 2021 to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. ... Read More
-
North America Respiratory Protective Equipment Market Databank
... 2021 to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of ... Read More
-
Asia-Pacific Respiratory Protective Equipment Market Databank
... to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of 3.64%. ... Read More
-
Leading Respiratory Protective Equipment Product Markets Databank
... 2021 to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of ... Read More
-
2022 Global In Vitro Lung Model Industry (2028 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include ... Read More
-
Global Cystic Fibrosis Therapeutics Market Databank
... to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail pharmacies ... Read More
-
Latin America, Middle East & Africa Respiratory Protective Equipment Market Databank
... CAGR of 3.69% from 2021 to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, ... Read More
-
Europe Respiratory Protective Equipment Market Databank
... to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of 3.64%. ... Read More
-
Leading Respiratory Protective Equipment End User Markets Databank
... from 2021 to 2029. Healthcare segment is expected to be the highest contributor to this market, with $8,070.9 Million in 2020, and is anticipated to reach $11,029.1 Million by 2029, registering a CAGR of 3.57%. ... Read More
-
Global Respiratory Protective Equipment Market Databank
... to 2029. Air-Purifying Respirators (APR) segment is expected to be the highest contributor to this market, with $9,163.2 Million in 2020, and is anticipated to reach $12,592.6 Million by 2029, registering a CAGR of 3.64%. ... Read More
-
Leading Respiratory Protective Equipment Country Markets Databank
... 2021 to 2029. North America is expected to be the highest contributor to this market, with $5,372.6 Million in 2020, and is anticipated to reach $7,088.5 Million by 2029, registering a CAGR of 3.16%. Asia-Pacific ... Read More
-
Europe Cystic Fibrosis Therapeutics Market Databank
... to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail pharmacies ... Read More
Research Assistance
